| |
|
|
|
CytRx Corporation  
|
|
0.5551 -0.002 (-0%) |
10-27 15:36 |
|
Open: |
0.59 |
Pre close: |
0.557 |
Target:
|
0.71 
|
|
High: |
0.59 |
Low: |
0.555 |
Resistance:
|
0.61
0.66
|
|
Volume: |
14,329 |
Market Cap: |
20M |
Support:
|
0.52
0.43
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.57
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.58 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.65 |
Stochastic Oscillator |
%K(14,3):
|
29.67 |
|
MA(250): |
0.54  |
%D(3): |
35.84 |
|
Average Volume(K) |
3-Month: |
5631
|
52-Week |
High:
|
0.85 |
|
10-Days: |
5039 |
Low: |
0.21 |
|
RSI |
RSI(14):
|
43.93 |
Change(%): |
91.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.209 |
Return on Equity (ttm) |
-45.0 |
Shares Out. (M) |
36.48 |
|
EPS Est. Current Year |
-0.500 |
Return on Assets (ttm) |
-25.3 |
Shares Float (M) |
27.43 |
|
EPS Est. Next Year |
-0.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.50 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.07 |
|
Forward EPS |
-0.220 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
294 |
|
Book Value (p.s.) |
0.380 |
EBITDA (p.s.) |
-0.197 |
P/E |
-2.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.46 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.76 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-2.09 |
P/CF |
-4.25 |
|
|
|
|
|
|
